Archives: Speakers
Aliona Gruzmann
Macarena Romero
Earl Tanmantiong
Earl Tanmantiong has served as Director and Chief Technology Officer of HBNB since March 3, 2025. In addition, Mr. Tanmantiong has served as Chief Technology Officer of Hotel101 Global since 2024. Prior to joining Hotel101 Global, Mr. Tanmantiong served as Founder and President of Earl Hotel Revenue Management Corp., a revenue management service provider for hotel chains in the Philippines, from 2017 to 2024; and as Director of Revenue Management for Hilton-branded hotels in Manhattan, New York City, from 2013 to 2016. Mr. Tanmantiong holds a Bachelor of Science in Hotel Administration, Cum Laude, from Cornell University.
Rana Banerji
With over two decades of experience spanning consulting, business development, and sales management, Rana serves as the pioneering sales leader for the ASEAN market at ClickHouse. Originally from Australia and now a long-time resident of Singapore, he has spent the last 15 years specializing in business analytics and database technologies. Rana is passionate about delivering tailored, cutting-edge solutions that meet both the immediate and future needs of his clients. Throughout his career, Rana has held key roles at industry-leading companies, including Confluent, Hasura, IBM, and Tridant, among others. His expertise lies in helping organizations unlock the full potential of their data through innovative strategies and solutions.
Wouter Bartholomeus, MD
Tània Nadal
Sven Öchsner
Stacy Lee
Stacy Lee is a Global Clinical Project Manager at Novotech. With a background in Human Biology and over 13 years of experience in global clinical operations, she has led multi-country oncology and radiopharmaceutical programs from early development through pivotal stages. Recognized as a subject matter expert in radiopharmaceutical clinical trials, Stacy specializes in translating complex science into operational strategy, proactive risk assessment, and mitigation planning to ensure trial integrity and delivery excellence. She is passionate about advancing targeted therapies and strengthening global partnerships to accelerate clinical development worldwide.